H1-receptor antagonists: Safety issues

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 5, 1999, Pages 481-488

  Simons, F Estelle R ^a  

^a CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ALCOHOL; ASTEMIZOLE; AZATADINE; AZELASTINE; BROMPHENIRAMINE; CETIRIZINE; CHLORPHENIRAMINE; CLEMASTINE; DIMENHYDRINATE; DIMETINDENE; DIPHENHYDRAMINE; DOXYLAMINE; EBASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOTIFEN; LEVOCABASTINE; LORATADINE; MEPYRAMINE; MEQUITAZINE; MIZOLASTINE; PROMETHAZINE; TERFENADINE; TRIAZOLAM; TRIPELENNAMINE; TRIPROLIDINE; UNINDEXED DRUG;

DRUG CLASSIFICATION; DRUG SAFETY; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HUMAN; INSOMNIA; MOTION SICKNESS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; UROGENITAL TRACT DISEASE; VISUAL IMPAIRMENT; XEROSTOMIA; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG EFFECT;

ASTEMIZOLE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; HISTAMINE H1 ANTAGONISTS; HUMANS; TERFENADINE;

EID: 0033227750     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62855-4     Document Type: Article

References (47)

1. 1-receptor antagonist drugs. N Engl J Med 1994;330: 1663-1670.
2. 1-receptor antagonists. Comparative tolerability and safety. Drug Safety 1994;10:350-380.
3. 1 antagonists measured by positron emission tomography. Br J Pharmacol 1995;116:1649-1655.
4. Snyder SH, Snowman AM. Receptor effects of cetirizine. Ann Allergy 1987;59:4-8.
5. Vuurman EFPM, van Veggel LMA, Uiterwijk MMC, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993;71:121-126.
6. Walsh JK, Muehlbach MJ, Schweitzer PK. Simulated assembly line performance following ingestion of cetirizine or hydroxyzine. Ann Allergy 1992;69:195-200.
7. Valk PJ, Simons RM, Struyvenberg PA, et al. Effects of a single dose of loratadine on flying ability under conditions of simulated cabin pressure. Am J Rhinol 1997;11:27-33.
8. O'Hanlon JF, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94. Allergy 1995;50:234-242.
9. Alford C, Rombaut N, Jones J, et al. Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: a C-EEG study. Hum Psychopharmacol Clin Exp 1992;7:25-35.
10. Seidel WF, Cohen S, Bliwise NG, Dement WC. Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standardized electroencephalographic assessment. J Allergy Clin Immunol 1990;86:1029-1033.
11. 1-receptor antagonists). Ann Allergy Asthma Immunol 1995; 75:507-514.
12. 1-receptor antagonists. Clin Exp Allergy 1996;26:1092-1097.
13. Hindmarch I, Bhatti JZ. Psychomotor effects of astemizole and chlorpheniramine, alone and in combination with alcohol. Int Clin Psychopharmacol 1987;2:117-119.
14. 1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol 1991;104:270-276.
15. Roehrs T, Zwyghuizen-Doorenbos A, Roth T. Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo. Sleep 1993;16: 301-305.
16. Goetz DW, Jacobson JM, Apaliski SJ, et al. Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine. Ann Allergy 1991;67: 448-454.
17. Schweitzer PK, Muehlbach MJ, Walsh JK. Sleepiness and performance during three-day administration of cetirizine or diphenhydramine. J Allergy Clin Immunol 1994;94:716-724.
18. Goetz DW, Jacobson JM, Murnane JE, et al. Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J Allergy Clin Immunol 1989;84:316-322.
19. 1-histamine receptor antagonist ebastine in 10, 20, and 30 mg dose, and triprolidine 10 mg on car driving performance. Br J Clin Pharmacol 1993; 36:67-70.
20. Simons FER. The eternal triangle: benefit, risk, and cost of therapeutic agents. Ann Allergy Asthma Immunol 1996;77:337-340.
21. Spencer CM, Faulds D, Peters DH. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993;46:1055-1080.
22. Stanley N, Alford CA, Rombaut NEI, Hindmarch I. Comparison of the effects of astemizole/pseudoephedrine and triprolidine/pseudoephedrine on CNS activity and psychomotor function. Int Clin Psychopharmacol 1996; 11:31-36.
23. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-1536.
24. Woosley RL. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 1996;36:233-252.
25. Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-2790.
26. Simons FER, Kesselman MS, Giddins NG, et al. Astemizole-induced torsade de pointes. Lancet 1988;2:624.
27. Pratt CM, Hertz RP, Ellis BE, et al. Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol 1994;73: 346-352.
28. Hanrahan JP, Choo PW, Carlson W, et al. Antihistamine-associated sudden death, ventricular arrhythmias, syncope and QT-interval prolongation: a comparison of terfenadine and other antihistamines. Post-Marketing Surveillance 1992;6:23-24.
29. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA 1996;275:1339-1341.
30. Burkhart GA, Sevka MJ, Temple R, Honig PK. Temporal decline in filling prescriptions for terfenadine closely in time with those for either ketoconazole or erythromycin. Clin Pharmacol Ther 1997;61:93-96.
31. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA 1996;275:1086-1087.
32. Honig PK, Wortham DC, Zamani K, Cantilena LR. Comparison of the effect of the macrolide antibiotics erythromycin, clarithromycin and azithromycin on terfenadine steady-state pharmacokinetics and electrocardiographic parameters. Drug Invest 1994; 7:148-156.
33. Rizack MA. The Medical Letter Handbook of Adverse Drug Interactions. New Rochelle, NY: The Medical Letter, Inc., 1997.
34. Honig PK, Wortham DC, Lazarev A, Cantilena LR. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 1996;36:345-351.
35. Lefebvre RA, Van Peer A, Woestenborghs R. Influence of itraconazole on the pharmacokinetics and electrocardiographic effects of astemizole. Br J Clin Pharmacol 1997;43:319-322.
36. Brannan MD, Reidenberg P, Radwanski E, et al. Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations. Clin Pharmacol Ther 1995;58:269-278.
37. Sanders RL, Dockhorn RJ, Alderman JL, et al. Cardiac effects of acrivastine compared to terfenadine. J Allergy Clin Immunol 1992;89:183.
38. Affrime MB, Lorber R, Danzig M, et al. Three month evaluation of electrocardiographic effects of loratadine in humans. J Allergy Clin Immunol 1993; 91:259.
39. Sale ME, Barbey JT, Woosley RL, et al. The electrocardiographic effects of cetirizine in normal subjects. Clin Pharmacol Ther 1994;56:295-301.
40. Geary III WJ, Garcia JD, Dockhom RJ. Electrocardiographic safety of 10 mg of ebastine in healthy elderly and young adult volunteers. Allergy 1995; 50:199.
41. Tinkelman D, Falliers C, Bronsky E, et al. Efficacy and safety of fexofenadine HCl in fall seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:435.
42. Bronsky EA, Meltzer EO, Perhach JL, et al. Cardiac safety of azelastine following 8 weeks of intranasal administration. J Allergy Clin Immunol 1997; 99:8445.
43. Crumb WJ Jr, Wible B, Arnold DJ, et al. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol 1995; 47:181-190.
44. Chen Y, Woosley RL. Electrophysiologic actions of astemizole. Clin Pharmacol Ther 1994;55:146.
45. Vorperian VR, Zhou Z, Mohammad S, et al. Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole. J Am Coll Cardiol 1996;28: 1556-1561.
46. Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol 1997;78:157-159.
47. Kauffman RE, Banner W Jr, Berlin CM Jr, et al. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-150.